Back to Newsroom

The Medicines Company to Present Data from its Investigational Anesthetic MDCO-700 at the ANESTHESIOLOGY® 2016 Annual Meeting and the ISAP 25th Annual Meeting

PARSIPPANY, N.J.–(BUSINESS WIRE)–Oct. 13, 2016– The Medicines Company (NASDAQ:MDCO) today announced that five abstracts with data from its investigational anesthetic MDCO-700 (formerly, ABP-700) development program will be presented at ANESTHESIOLOGY® 2016, the annual meeting of the American Society of Anesthesiologists (ASA), being held at the McCormick Place in Chicago from October 22-26, 2016 and at the International Society for Anaesthetic Pharmacology 25th Annual Meeting (ISAP) taking place at the Hyatt Regency Chicago on October 21, 2016.

Click here to read the full release